Difference between revisions of "Laurie Flynn"
m |
|||
| Line 6: | Line 6: | ||
<references/> | <references/> | ||
| − | [[Category:Health]] | + | [[Category:Health]][[Category:Pharma]] |
Latest revision as of 08:10, 15 March 2009
Laurie Flynn is reported to be[1] Director of Columbia University’s Teenscreen Program since 2001 (see Pharmaceutical Industry, PR and Mental Health Screening) alongside Michael Hogan who serves on the Advisory Board. Flynn previously served 16 years as the Executive Director of the National Alliance on Mental Illness (NAMI).
Flynn and Michael Hogan were involved in the Expert Consensus Guideline Series: Treatment of Schizophrenia 1999 an initiative aiming at establishing uniform medication guidelines for schizophrenia[2]. It is reported that this was an initiative 'supported exclusively by 6 pharmaceutical companies: Eli Lilly and Company, Janssen Pharmaceutica Inc., Novartis Pharmaceuticals Corporation, Ortho-McNeil Pharmaceutical, Pfizer Inc. and Zeneca Pharmaceuticals' (now known as AstraZeneca).
References
- ↑ Weibert, S. The Genesis of President Bush’s New Freedom Commission on Mental Health Teenscreen Truth. Accessed 9th January 2008
- ↑ Weibert, S. The Genesis of President Bush’s New Freedom Commission on Mental Health Teenscreen Truth. Accessed 9th January 2008
